ELC Hosts Scientific Advisory Board to Advance Dermatological Science

The Estée Lauder Companies (ELC) recently convened a Scientific Advisory Board (SAB) meeting, titled "Skin Tone & Pigmentation Management: From Skincare to Dermatological Procedures" Hosted at ELC’s China Innovation Labs, this gathering brought together leading external dermatologists from China and Korea to exchange insights on the latest advancements in dermatology and best practices for addressing skin tone and pigmentary concerns.

The meeting featured insightful presentations from ELC R&D leaders and external experts, followed by an engaging panel discussion. The sessions provided a comprehensive overview of the latest mechanisms, treatments, and research insights related to hyperpigmentation and aging skin, with a particular emphasis on post-inflammatory hyperpigmentation (PIH) and skin tone variation prevalent in the Chinese population.

Justin He, Vice President, APAC R&D and Innovation, ELC, remarked, "Skin tone and pigmentation management continue to be among the most sought-after cosmetic benefits, especially in Asia. We remain committed to partnering with external leaders in dermatological science and leveraging their scientific insights to develop advanced solutions that reflect the evolving needs of our consumers"

ELC’s R&D team also shared novel findings on innovative methods for managing skin tone and pigmentation, highlighting the company’s ongoing dedication to scientific excellence and consumer-centric innovation. During the panel, advisory board members reviewed ELC’s research pipeline, offering valuable insights on future innovation and development.

Pigmentation concerns and uneven skin tone are common among our patients in Asia, and significantly impact their quality of life" commented Dr. Leihong Flora Xiang, Professor at Huashan Hospital, Fudan University. "I was delighted to join ELC’s scientific advisory board meeting because through partnerships with the cosmetics industry, we can develop effective solutions that align with the specific needs of our patients"

In addition to showcasing existing and emerging research, the event fostered a collaborative environment for clinical experts and ELC scientists. It reinforced ELC’s commitment to pioneering breakthrough research in dermatological science, aiming to develop prestige skin care solutions that blend science with performance for the company’s consumers in Asia and globally.   

Around the world, ELC is dedicated to cutting-edge science with multidisciplinary expertise ranging from basic science and advanced technologies to the intersections of physics, chemistry, biology, and engineering. ELC R&D has 75 years of formulation authority and is deeply integrated into the scientific community, regularly presenting at leading events and publishing in peer-reviewed journals. ELC’s R&D team consistently aims to develop the next generation of transformative, science-driven prestige beauty products, packaging, and experiences that deliver exceptional quality and performance for our consumers around the world.

About The Estée Lauder Companies Inc.

The Estée Lauder Companies Inc. (ELC) is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.